Robert Albert Zerbib
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Complement system in diseases
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Multiple Myeloma Research and Treatments 7
-
- Immune Cell Function and Interaction 6
- Co-authors
- Pascale André (7 shared papers)Eric D. Vivier (2 shared papers)Thorbald van Hall (1 shared paper)Amir Horowitz (1 shared paper)Dan Fu Ruan (1 shared paper)Émilie Narni-Mancinelli (1 shared paper)Sjoerd H. van der Burg (1 shared paper)H Laborit (4 shared papers)
- Journals
- Blood (5 papers)Annals of Oncology (3 papers)Critical Care (1 paper)Bone Marrow Transplantation (1 paper)Cell (1 paper)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Robert Albert Zerbib
28 papers receiving 2.3k citations
Robert Albert Zerbib's Hit Papers
Peers
Comparison fields: 5 of 90
- Immunology 1.4k
- Oncology 994
- Hematology 225
- Infectious Diseases 355
- Neurology 132
Countries citing papers authored by Robert Albert Zerbib
This map shows the geographic impact of Robert Albert Zerbib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Albert Zerbib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Albert Zerbib more than expected).
Fields of papers citing papers by Robert Albert Zerbib
This network shows the impact of papers produced by Robert Albert Zerbib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Albert Zerbib. The network helps show where Robert Albert Zerbib may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Albert Zerbib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells Hit paper breakdown → | 2018 | 976 |
| 2 | 2020 | 414 | |
| 3 | 2019 | 233 | |
| 4 | 2015 | 159 | |
| 5 | 2018 | 116 | |
| 6 | 2022 | 110 | |
| 7 | 2011 | 48 | |
| 8 | Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study. | 2006 | 43 |
| 9 | Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors. | 1993 | 40 |
| 10 | 2011 | 19 | |
| 11 | 2019 | 18 | |
| 12 | 2019 | 16 | |
| 13 | 1990 | 15 | |
| 14 | 2018 | 14 | |
| 15 | 2020 | 12 | |
| 16 | 2005 | 11 | |
| 17 | 2024 | 7 | |
| 18 | 2013 | 6 | |
| 19 | 2023 | 6 | |
| 20 | Role of various second messengers in the memorization of a passive or active avoidance | 1987 | 5 |
About Robert Albert Zerbib
Robert Albert Zerbib is a scholar working on Hematology, Immunology, Oncology, Infectious Diseases and Genetics, having authored 28 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Immune Cell Function and Interaction (6 papers), COVID-19 Clinical Research Studies (4 papers), CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Treatment and Pharmacology (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (994 citations), Hematology (225 citations), Infectious Diseases (355 citations) and Neurology (132 citations). Robert Albert Zerbib has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Pascale André, Eric D. Vivier, Thorbald van Hall, Amir Horowitz, Dan Fu Ruan, Émilie Narni-Mancinelli, Sjoerd H. van der Burg, H Laborit, Yvonne Adeduni Efebera and Michael A. Caligiuri. Their work appears in journals such as Blood, Annals of Oncology, Critical Care, Bone Marrow Transplantation and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.